Gisela Sparmann

1.4k citations
53 papers · 1.1k indexed · h-index 22
Topics
Pancreatitis Pathology and Treatment (23 papers)Pancreatic and Hepatic Oncology Research (17 papers)Pancreatic function and diabetes (6 papers)

In The Last Decade

Gisela Sparmann

52 papers receiving 1.1k citations

Peers

Gisela Sparmann
Comparison fields: 5 of 98
  • Surgery 571
  • Oncology 473
  • Molecular Biology 345
  • Immunology 321
  • Epidemiology 146
Replace Yoshitaka Konda with:
Yoshitaka Konda Japan
Tsuyoshi Tachibana Japan
Tetsuhisa Yamamoto Japan
Wim H.A. Dokter Netherlands
Yoshifumi Nakayama Japan
M. Ueda Japan
Jinbiao Chen Australia
Russell Ericksen United States
Qing Chen China
Yasuko Nishizawa Japan
Gisela Sparmann relative to Yoshitaka Konda Japan Yoshitaka Konda's profile →
Citations per field
00.5×2.7×
Yoshitaka Konda · 1×
Citations per year

Countries citing papers authored by Gisela Sparmann

Since Specialization
Citations

This map shows the geographic impact of Gisela Sparmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gisela Sparmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gisela Sparmann more than expected).

Fields of papers citing papers by Gisela Sparmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gisela Sparmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gisela Sparmann. The network helps show where Gisela Sparmann may publish in the future.

Co-authorship network of co-authors of Gisela Sparmann

This figure shows the co-authorship network connecting the top 25 collaborators of Gisela Sparmann. A scholar is included among the top collaborators of Gisela Sparmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gisela Sparmann. Gisela Sparmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1
Greening Software with Continuous Energy Efficiency Measurement.
2
2 36
3 27
4 8
5 42
6 20
7 26
8 24
9 23
10 22
11 7
12 57
13 12
14 19
15 24
16 7
17 8
18 3
19 107
20 3

About Gisela Sparmann

Gisela Sparmann is a scholar working on Oncology, Immunology and Surgery, having authored 53 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pancreatitis Pathology and Treatment (23 papers), Pancreatic and Hepatic Oncology Research (17 papers) and Pancreatic function and diabetes (6 papers). The work is most often cited by research in Oncology (473 citations), Immunology (321 citations) and Surgery (571 citations). Gisela Sparmann has collaborated with scholars based in Germany, Japan and United States. Frequent co-authors include Jörg Emmrich, Stefan Liebe, Robert Jaster, Brit Fitzner, Peter Brock, Ludwig Jonas, Matthias Löhr, Jutta Merkord, S Liebe and Eberhard Hofmann. Their work appears in journals such as The Journal of Immunology, Gastroenterology and Gut.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026